Skip to content
CIFAR header logo
fr
menu_mobile_logo_alt
  • News
  • Events
    • Public Events
    • Invitation-only Meetings
  • Programs
    • Research Programs
    • Pan-Canadian AI Strategy
    • Next Generation Initiatives
    • Global Call for Ideas
  • People
    • Fellows & Advisors
    • CIFAR Azrieli Global Scholars
    • Canada CIFAR AI Chairs
    • AI Strategy Leadership
    • Solution Network Members
    • Leadership
  • Support Us
  • About
    • Our Story
    • CIFAR 40
    • Awards
    • Partnerships
    • Publications & Reports
    • Careers
    • Staff Directory
    • Equity, Diversity & Inclusion
  • fr
CIFAR in the News

Scientific American | How AI Could Prevent the Development of New Illicit Drugs

By: Justine Brooks
5 Jan, 2022
January 5, 2022
markus-spiske-iar-afB0QQw-unsplash

Scientific American published an article on January 5, 2022, highlighting work done in part by Canada CIFAR AI Chair, Russell Greiner, on an algorithm called DarkNPS. The algorithm helps to identify potential designer drugs that may not even exist yet, allowing governments to stay one step ahead. 

How AI Could Prevent the Development of New Illicit Drugs

  • Follow Us

Related Articles

  • What will be the impact of AI-assisted robotics on humanity?
    February 15, 2023
  • CIFAR, Amii and the Vector Institute name eight new Canada CIFAR AI Chairs
    October 27, 2022
  • Believe the Impossible: The Future of… Fairness in AI
    September 12, 2022
  • Toronto Star | Can we make artificial intelligence less racist?
    June 22, 2022

Support Us

CIFAR is a registered charitable organization supported by the governments of Canada, Alberta and Quebec, as well as foundations, individuals, corporations and Canadian and international partner organizations.

Donate Now
CIFAR header logo

MaRS Centre, West Tower
661 University Ave., Suite 505
Toronto, ON M5G 1M1 Canada

Contact Us
Media
Careers
Accessibility Policies
Supporters
Financial Reports
Subscribe

  • © Copyright 2023 CIFAR. All Rights Reserved.
  • Charitable Registration Number: 11921 9251 RR0001
  • Terms of Use
  • Privacy
  • Sitemap

Subscribe

Stay up to date on news & ideas from CIFAR.

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.
Accept Learn more